Literature DB >> 12198697

Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes.

Timothy R Orchard1, C N Chua, Tariq Ahmad, Hung Cheng, Kenneth I Welsh, Derek P Jewell.   

Abstract

BACKGROUND & AIMS: There are few systematic studies on the natural history or immunogenetic associations of erythema nodosum (EN) or ocular inflammation in inflammatory bowel disease (IBD), but they are reportedly more common in patients with other extraintestinal manifestations (EIMs), particularly arthritis. Immunogenetic associations have previously been described in IBD arthritis and in EN associated with sarcoidosis. This study examined the clinical features and HLA-B, DR, and tumor necrosis factor alpha (TNF-alpha) associations of ocular inflammation and EN and their clinical and immunogenetic relationship to arthritis in IBD.
METHODS: Details of EN and ocular inflammation were gathered by case-note review and questionnaire in 976 ulcerative colitis patients and 483 Crohn's patients. Sequence-specific PCR typing for polymorphisms in HLA-B, DR, and TNF-alpha was performed in 39 EN and 40 ocular patients. Results were compared with 490 IBD controls without EIMs, 38 patients with type 1 and 31 with type 2 peripheral arthritis, and 16 AS patients.
RESULTS: EN and ocular inflammation were more common in women, were associated with IBD relapse, and recurred in approximately 30% of patients. They occurred more commonly with arthritis and AS than expected by chance. Ocular inflammation was strongly associated with HLA-B*27, B*58, and HLA-DRB1*0103. There is a weak association between EN and HLA-B*15 but a strong association with the -1031 TNF-alpha.
CONCLUSIONS: EN, uveitis, and arthritis associated with IBD occur together commonly. They are associated with genes in the HLA region, and linkage disequilibrium between these genes may account for the clinical picture of overlapping but independent clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198697     DOI: 10.1053/gast.2002.35396

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  56 in total

Review 1.  Extraintestinal complications of inflammatory bowel disease.

Authors:  Tim Orchard
Journal:  Curr Gastroenterol Rep       Date:  2003-12

2.  Choosing Therapy on the Basis of Disease Classifications in Inflammatory Bowel Disease.

Authors:  Maria T. Abreu
Journal:  Curr Treat Options Gastroenterol       Date:  2004-06

3.  Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.

Authors:  Sasha Taleban; Dalin Li; Stephan R Targan; Andrew Ippoliti; Steven R Brant; Judy H Cho; Richard H Duerr; John D Rioux; Mark S Silverberg; Eric A Vasiliauskas; Jerome I Rotter; Talin Haritunians; David Q Shih; Marla Dubinsky; Gil Y Melmed; Dermot P B McGovern
Journal:  J Crohns Colitis       Date:  2015-10-08       Impact factor: 9.071

4.  Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.

Authors:  Konstantinos Karmiris; Anastasios Avgerinos; Aikaterini Tavernaraki; Christos Zeglinas; Pantelis Karatzas; Theodoros Koukouratos; Konstantinos A Oikonomou; Athanasios Kostas; Evanthia Zampeli; Vasileios Papadopoulos; Angeliki Theodoropoulou; Nikos Viazis; Dimitrios Polymeros; Spyridon Michopoulos; Giorgos Bamias; Andreas Kapsoritakis; Dimitrios G Karamanolis; Gerassimos J Mantzaris; Charalampos Tzathas; Ioannis E Koutroubakis
Journal:  J Crohns Colitis       Date:  2015-12-30       Impact factor: 9.071

Review 5.  An update on the genetics of HLA B27-associated acute anterior uveitis.

Authors:  Tammy M Martin; James T Rosenbaum
Journal:  Ocul Immunol Inflamm       Date:  2011-04       Impact factor: 3.070

Review 6.  Emerging role of antioxidants in the protection of uveitis complications.

Authors:  U C S Yadav; N M Kalariya; K V Ramana
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 7.  Genetics of inflammatory bowel disease: current status and future directions.

Authors:  Thomas D Walters; Mark S Silverberg
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

Review 8.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 9.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  Folashade A Jose; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-02       Impact factor: 2.839

10.  Inflammatory bowel disease: one or two diseases?

Authors:  David B Sachar; Aaron Walfish
Journal:  Curr Gastroenterol Rep       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.